ReviewInnere Medizin (Heidelberg, Germany)2026
[Immune complex- and complement-mediated glomerulonephritides].
Review in Innere Medizin (Heidelberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Glomerulonephritis represents a heterogeneous group of kidney diseases characterized by inflammation of the glomeruli and capable of leading to acute or chronic kidney failure. In addition to the primary glomerulonephritides described elsewhere in this issue, there is a group of diseases in which immune complex deposition or disturbances in complement regulation play a central pathogenic role. Among the most important and clinically relevant forms of these immune complex- and complement-mediated glomerulonephritides are postinfectious glomerulonephritis (PIGN), lupus nephritis (LN), cryoglobulinemic glomerulonephritis, and C3 glomerulopathy (C3G). While PIGN, LN, and cryoglobulinemic glomerulonephritis are characterized by glomerular immune complex deposits, C3 glomerulopathy is primarily based on a dysregulation of the alternative complement pathway. These diseases require specialized treatment in university outpatient clinics in collaboration with nephrology practices. Renal biopsy is a key diagnostic tool, and histologically, a membranoproliferative pattern is frequently observed. This article provides a systematic overview of immune complex- and complement-mediated glomerulonephritis and compares their pathogenesis, clinical presentation, immunoserological profiles, histology, and available therapies.
Indexed as
Identifiers
42012503What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.